Educational Solutions for Workforce Development Pharmacy Significant Event Analysis Fiona McMillan Lead Pharmacist Educational Development April 2014.

Slides:



Advertisements
Similar presentations
National Reporting & Learning System (NRLS) Reporting systems are vital in providing a core of sound, representative information on which to base analysis.
Advertisements

The Individual Health Plan Essential to achieve educational equality for students with health management needs Ensures access to an education for students.
MAG form by GMP domains Susi Harris Calderdale PCT GP Appraisal Lead.
The Aged Care Standards and Accreditation Agency Ltd Continuous Improvement in Residential Aged Care.
Developing Patient Safety in Primary Care in Scotland Neil Houston, Arlene Napier.
Standard 6: Clinical Handover
Facility Level Reviews Photo from:
Significant Event Analysis
Implementing the Single Assessment Process across the South West Peninsula Basic awareness.
WELCOME MANAGING ATTENDANCE GOVERNOR / PRINCIPAL TRAINING MARCH 2012.
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download, adapt, and distribute this.
Practical Effective Steps to Improve Trial QUALITY from Audit/Inspections findings Cancer Clinical Trials Unit Scotland A NCRI Accredited Cancer Trials.
Protecting patients- now and in the future Linda Matthew Senior Pharmacist National Patient Safety Agency.
Enhanced Significant Event Analysis in General Practice
Modernising Pharmacy Regulation An inspector calls: A new regulatory model in pharmacy Mark Voce Head of Inspection, GPhC Date.
Questions or comments on this presentation can be addressed to You can pick and choose the elements.
Learning Objectives  Recognize the need for an investigation  Investigate the scene of the accident  Interview victims & witnesses  Distinguish.
YJB TOOLKITS: Disproportionality YJB owner: Sue Walker Dept: Performance May (2011) Version 1.0.
The New Patient Safety Net How to enter a report.
Benefits for using a standardised risk management framework to risk assess Infection Prevention and Control Sue Greig Senior Project Officer National.
Medication Safety Standard 4 Part 3 – Documentation of Patient Information, Continuity of Medication Management Margaret Duguid, Pharmaceutical Advisor.
Accident Investigation.
Learning about Safe Systems Dr. Maureen Baker CBE DM FRCGP Clinical Director for Patient Safety NHS Connecting for Health.
Solution Overview for NIPDEC- CDAP July 15, 2005.
RAPID IMPROVEMENT EVENT involving partner organisations
Topic 4 How organisations promote quality care Codes of Practice
Module 3. Session DCST Clinical governance
1 Accreditation and Certification: Definition  Certification: Procedures by which a third party gives written assurance that a product, process or service.
Educational Solutions for Workforce Development Pharmacy Significant Event Analysis Analysis of an event to change practice Val Reilly SEA Reviewer NHS.
Clinical Risk Unit University College London International Perspectives Feedback from the review board Charles Vincent Clinical Risk Unit University College.
Increasing Pharmacists reporting of adverse medication incidents Being Ready for new risks and Opportunities Prepared by Tim Garrett Northern Sydney Central.
Educational Solutions for Workforce Development Pharmacy Significant Event Analysis Fiona McMillan Lead Pharmacist Educational Development.
Quality Education for a Healthier Scotland Audit Fiona McMillan Lead Pharmacist Educational Development NHS Education for Scotland.
Medication Use Process Part One, Lecture # 5 PHCL 498 Amar Hijazi, Majed Alameel, Mona AlMehaid.
Accident Investigation S afety A wareness F or E veryone from Cove Risk Services.
ISO NON-CONFORMANCE, CORRECTIVE AND PREVENTIVE ACTION.
Audit and SEA Made Easy GPST Teaching, Beardmore, November 2010 Mairi Jamieson GPST Course Organiser NHS Education for Scotland.
Identifying Systemic Issues and Improving Customer Service Annette Donselaar ASM BA BCom MComLaw LLM DFP Grad Dip Compliance AACI Head of Australian Region.
Significant Events. Significant Event Analysis (SEA) An SEA is concerned with investigating any occurrence which are identified by any practice members.
Managing Hospital Safety: Common Safety Concerns Part 1 of 4.
Using drug use evaluation (DUE) to optimise analgesic prescribing in emergency departments (EDs) Karen Kaye, Susie Welch. NSW Therapeutic Advisory Group*
Quality Education for a Healthier Scotland Pharmacy Pharmaceutical Care Planning Vocational Training Scheme: Level = Stage 2 Arlene Shaw Specialist Clinical.
Implementing the Single Assessment Process across the South West Peninsula Basic awareness.
Significant Event Analysis Paul Myres Primary Care Quality Information Service March 2011.
European Patients’ Academy on Therapeutic Innovation Introduction to pharmacovigilance Monitoring the safety of medicines.
Medicines Reconciliation A Whole System Approach Arlene Coulson Principal Clinical Pharmacist, Specialist Services Gordon Thomson Principal Clinical Pharmacist,
How the Clinical Effectiveness Team can help you to audit your Prescribing Practice Jude Scott Clinical Governance & Risk Management Unit Clinical Effectiveness.
Content from National Patient Safety Agency material 2 Day Lead Investigator.
RISK MANAGEMENT FOR COMMUNITY EVENTS. Today’s Session Risk Management – why is it important? Risk Management and Risk Assessment concepts Steps in the.
Educational solutions for the NHS pharmacy workforce Medicines Optimisation: Helping patients to make the most of medicines Sue Carter Regional Tutor
Communication and Optimal Resolution (CANDOR) Toolkit Module 4: Event Reporting, Event Investigation and Analysis.
GB.DRO f, date of preparation: January 2010 Dartford and Gravesham NHS Trust Pharmacy Services in Hospital.
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
Safety in Medicines: Raising the profile with the Royal Pharmaceutical Society Liz Rawlins Communications Officer 9 May 2011.
Content from National Patient Safety Agency material 1 Day Support Investigator.
Reducing medication errors Key slides In association with National Patient Safety Agency (NPSA)
Purpose of tonight Consider the issues and what we currently do
Risk Communication in Medicines
Methotrexate in Psoriasis Shared Care Guidelines
Introduction to Root Cause Analysis
Audit and SEA Made Easy GPST Teaching Dr Kate Lewin
Gill Butler NW Pharmacist Trainers Steering Group
Facility Level Reviews
Learning from Significant Events
Managing a Research Project
CITE THIS CONTENT: RYAN MURPHY, “EVENT REPORTING”, ACCELERATE UNIVERSITY OF UTAH HEALTH CURRICULUM, JUNE 1, 2018 (Updated August 24, AVAILABLE AT: 
Medication Reconciliation
Practice-related feedback
OTLA Report Writing Training
Accident Investigation.
Presentation transcript:

Educational Solutions for Workforce Development Pharmacy Significant Event Analysis Fiona McMillan Lead Pharmacist Educational Development April 2014

Aim To provide information about the analysis of a Significant Event (SE)

‘To err is human, to cover up is unforgivable and to fail to learn is inexcusable’’ Liam Donaldson 2004

Background SEA embedded medical model Effective analysis allows reflection and learning within the team Positive and negative events Safe and effective medicines management needs systems to ensure that patient safety is maintained. Sharing practice aids development of good practice.

Educational Solutions for Workforce Development Pharmacy What is a Significant Event? “Any event thought by anyone in the health care team to be significant in the care of patients or the conduct of the practice or organisation.’ Pringle et al, 1995

Examples of Significant Events Wrong drug prescribed Wrong drug dispensed Patient complaints IT issue leading to error Drug interaction not noted Medication labelled incorrectly Lack of communication within healthcare team Issues with training

What is the process for analysis and receiving peer comments? Complete SEA proforma Discuss at peer review + include all involved Update Submit to NES Feedback Share again with peers

The Seven Stages of Significant Event Analysis Stage 1: Awareness and prioritisation of a significant event Significant events should be prioritised for analysis based on their consequences (actual or potential) for the quality and safety of patient care. Stage 2: Information gathering Collect information before the SEA meeting using both documentation sources (PMR, SOPs, protocols etc) and from personal accounts (patients, relatives, healthcare staff and individuals from other agencies).

Stage 3: The facilitated healthcare team-based meeting It is important to invite all relevant staff to the meeting. Learning needs have to be identified and the meeting should be conducted in an open, fair, honest and non-threatening atmosphere. Stage 4: Analysis of the Significant Event The Four What's: What happened? Why did it happen? What has been learned? What has been changed or actioned?

Stage 5: Agree, implement and monitor change This is vital to the success of the analysis of the Significant Event. Stage 6: Write it up Written records should be kept using the NES Significant Event Analysis documentation: training/by-discipline/pharmacy/pharmacists/cpd-audit-sea/significant- event-analysis-for-pharmacy-staff.aspxhttp:// training/by-discipline/pharmacy/pharmacists/cpd-audit-sea/significant- event-analysis-for-pharmacy-staff.aspx Stage 7: Report, share and review......

Stage 4 Questions in SEA form What happened? Give adequate detail to enable reviewers to understand the whole picture. Why did it happen? Explain reasons from your analysis by establishing the underlying reasons. What have you learned? Outline the learning needs identified and show that reflection and learning has taken place. What have you changed? Will this prevent reoccurrence?

Example of a SEA Form and Peer Feedback NES will make your details anonymous before sending it to be peer reviewed

The possible consequences for the patient were well described but does not mention the possible impact the event will have on the staff Described what actually happened... Set the scene.... Who was involved? In your view why did it happen?

Usually there is a range of errors or shortcomings which causes the single event so they should all be identified and addressed

It is vital that all patient and staff details are omitted in this form Described your learning....involve other members of the team.... in the discussions...

What actions have you taken as a result of analysing the event?

The feedback is sent back to the submitter as a letter via .

Benefits of SEA Peer reviewers Peer review Recording and discussion with peers Individual analysis Joint Learning + improved patient care

Why is SEA important? Analysis will help to reduce manage and reduce risks. Reflection allows time to reflect on the event and understand the reasons why it occurred. Reflection also fulfils some of the CPD requirements. Identifies your own learning needs as well as those in the healthcare team.